Eulerpool Terminal
The edge that pays for itself.
Current Context Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
5.78 USD
+1,147.31 %
Median
5.61 USD
+1,110.62 %
Max
7.35 USD
Min
4.04 USD
Last Price
0.46 USD
Buy
15
Hold
1
Sell
0
The average target price for Context Therapeutics is 5.78 USD. (+1,147.31 % above the current price)
The median price target of Context Therapeutics is 5.61 USD.
Stock analysts from many renowned investment banks are closely examining the Context Therapeutics stock. They conclude their professional Context Therapeutics stock analyses with a clear recommendation for the Context Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-04-01 | 15 | 1 | 0 | — |
| 2026-03-01 | 15 | 1 | 0 | 5.78 USD |
| 2026-02-01 | 14 | 1 | 0 | 5.10 USD |
| 2026-02-01 | 14 | 1 | 0 | 5.30 USD |
| 2026-01-01 | 14 | 1 | 0 | 5.95 USD |
| 2025-12-01 | 13 | 1 | 0 | 5.44 USD |
Context Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Context Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 2.00 M USD | -37.00 M USD | -0.40 USD |
| 2028e | 2.00 M USD | -50.00 M USD | -0.54 USD |
| 2029e | 10.00 M USD | -43.00 M USD | -0.47 USD |